If liver or biliary disease is in the differential, a hepatic ultrasound is indicated.

This liver ultrasound reveals a mass in the liver.

Monitoring by blood alfafoetoprotein assay and hepatic ultrasound is performed at 3 months and then every 6 months for 2 years.

According to the above, hepatic ultrasound is performed to describe or better delineate the architecture of the liver, especially in the presence of suspected symptoms or clinical examinations.

Investigators performed liver ultrasound on more than 1,100 adolescents aged 17 years, who have been followed since before birth as part of the Western Australian Pregnancy (Raine) Cohort study.

A liver ultrasound will show that steatosis is present only if it represents more than 30% of the liver tissue.